Skip to main content
. 2019 Nov 26;11(12):694. doi: 10.3390/toxins11120694

Figure 5.

Figure 5

Inflammatory responses in mice administration with α-MMC and α-MMC plus TPCA-1. ICR mice were treated with α-MMC (6 mg/kg), IKKβ inhibitor TPCA-1 (15 mg/kg), or their combination for three constitutive days. LPS (10 mg/kg) was used as positive control. Levels of IL-1β, TNF-α, and MCP-1 in the sera were detected by ELISA. The data present the mean ± S.E.M., n = 4. Significant differences: * p < 0.05.